PHARMACYTE BIOTECH, INC. Fair Value Adjustment of Warrants
PHARMACYTE BIOTECH, INC. (PMCB) reported Fair Value Adjustment of Warrants of $469.00 thousand for the 3-month period ending 2025-07-31, per its 10-Q filed 2025-09-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-07-29
- PHARMACYTE BIOTECH, INC. fair value adjustment of warrants for the quarter ending 2025-07-31 was $469.00K.
- PHARMACYTE BIOTECH, INC. fair value adjustment of warrants for fiscal 2025 was $469.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|
| 2025-07-31 | $469.00K 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $469.00K 10-K · filed 2026-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |